Cidara Therapeutics Inc (CDTX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

6310 NANCY RIDGE DRIVE SAN DIEGO, CA 92121

Cidara Therapeutics Inc. isa is developing long-acting therapeutics designed to transform the standard of care for patients facing serious fungal or viral infections. The Company's portfolio is comprised of its lead antifungal candidate, rezafungin, in addition to antiviral conjugates (AVCs) for the prevention and treatment of influenza and other viral diseases from Cidara's proprietary Cloudbreak® antiviral platform. Cidara is headquartered in San Diego, California.

Data as of 2021-10-09 10:18:50 -0400
Market Cap79.21 Million Shares Outstanding49.506 Million Avg 30-day Volume496.98 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-2.01 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.8007 52-week High/Low3.27 / 1.46 Next Earnings Date2021-11-04 Price to Cash FLow (P/CF) 9.4235
Data provided by IEX Cloud
View SEC Filings from CDTX instead.

View recent insider trading info

Funds Holding CDTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CDTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

57 Thousand total shares from 3 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DARUWALA PAUL CHIEF OPERATING OFFICER

  • Officer
182,531 2021-09-30 3

SANDISON TAYLOR CHIEF MEDICAL OFFICER

  • Officer
236,631 2021-09-30 3

JOHNSON BRADY VICE PRESIDENT, FINANCE

  • Officer
47,199 2021-09-30 4

TARI LESLIE CHIEF SCIENTIFIC OFFICER

  • Officer
163,849 2021-09-30 3

FRANSON TIMOTHY R

  • Director
11,000 2021-09-13 2

SHAH PREETAM CFO & CBO

  • Officer
0 2021-09-01 2

WARD SHANE CHIEF LEGAL OFFICER

  • Officer
0 2021-08-25 2

STEIN JEFFREY PRESIDENT & CEO

  • Officer
  • Director
1,095,367 2021-08-18 4

BURGESS DANIEL D

  • Director
17,500 2021-06-23 1

SCHROEDER THEODORE R

  • Director
17,500 2021-06-23 1

MINEO CHRYSA

  • Director
17,500 2021-06-23 1

BASSLER BONNIE L

  • Director
17,500 2021-06-23 3

GOLLAHER DAVID L

  • Director
17,500 2021-06-23 1

CANALE-THEAKSTON CARIN

  • Director
17,500 2021-06-23 3

LEVINE JAMES E. CHIEF FINANCIAL OFFICER

  • Officer
249,803 2021-03-17 2

ABDOLLAHIAN NEIL CHIEF BUSINESS OFFICER

  • Officer
208,308 2021-03-17 2

OIEN JESSICA GENERAL COUNSEL & SECRETARY

  • Officer
135,000 2021-03-17 2

MUNDIPHARMA AG

  • 10% Owner
4,781,408 2019-09-03 0

ROCKLAGE SCOTT M

  • Director
0 2018-06-13 0

ONAITIS MATTHEW GNRL COUNSEL, CFO & SECRETARY

  • Officer
0 2018-03-29 0

BIOTECH TARGET N V

BB BIOTECH AG

  • 10% Owner
2,295,272 2017-11-15 0

WILSON MARC CHIEF ACCOUNTING OFFICER

  • Officer
10,356 2017-09-18 0

PEREZ ROBERT J

  • Director
0 2017-06-22 0

BARTIZAL KEN CHIEF DEVELOPMENT OFFICER

  • Officer
0 2017-03-31 0

FORREST KEVIN CHIEF SCIENTIFIC OFFICER

  • Officer
72,354 2017-03-31 0

THYE DIRK CHIEF MEDICAL OFFICER

  • Officer
0 2016-03-16 0

ROCKLAGE SCOTT M

5AM CO-INVESTORS III, L.P.

5AM VENTURES III, L.P.

DIEKMAN JOHN D

SCHWAB ANDREW J.

  • Director
  • 10% Owner
2,006,511 2015-04-20 0

ELMS STEVE

  • Director
1,054,610 2015-04-20 0

HERON PATRICK J

  • Director
No longer subject to file 2015-04-20 0

KJELLSON NINA S

  • Director
No longer subject to file 2015-04-20 0

AISLING CAPITAL II LP

AISLING CAPITAL PARTNERS, LP

AISLING CAPITAL PARTNERS LLC

SCHIFF ANDREW N

PURCELL DENNIS J

SEACHAID PHARMACEUTICALS, INC.

  • 10% Owner
703,092 2015-04-14 0

JUDICE KEVIN

  • Director
94,488 2015-04-14 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

SANDISON TAYLOR - Officer CHIEF MEDICAL OFFICER

2021-10-04 21:31:08 -0400 2021-09-30 A 150,600 a 236,631 direct -3.0612 -12.7551 0.0 1 -18.3673 4

JOHNSON BRADY - Officer VICE PRESIDENT, FINANCE

2021-10-05 21:26:44 -0400 2021-09-30 A 20,750 a 47,119 direct -1.5789 -3.1579 0.0 1 -15.7895 3

DARUWALA PAUL - Officer CHIEF OPERATING OFFICER

2021-10-04 21:27:26 -0400 2021-09-30 A 132,000 a 182,531 direct -3.0612 -12.7551 0.0 1 -18.3673 4

JOHNSON BRADY - Officer VICE PRESIDENT, FINANCE

2021-10-04 21:38:25 -0400 2021-09-30 A 20,750 a 47,199 direct -3.0612 -12.7551 0.0 1 -18.3673 4

TARI LESLIE - Officer CHIEF SCIENTIFIC OFFICER

2021-10-04 21:23:56 -0400 2021-09-30 A 148,000 a 150,551 direct -3.0612 -12.7551 0.0 1 -18.3673 4

FRANSON TIMOTHY R - Director

2021-09-14 19:59:09 -0400 2021-09-13 P 7,000 $2.12 a 11,000 direct 0.0 7.177 7.177 6 0.0 1

SHAH PREETAM - Officer CFO & CBO

2021-09-03 16:32:11 -0400 2021-09-01 A 50,000 a 50,000 direct

SHAH PREETAM - Officer CFO & CBO

2021-09-03 16:32:11 -0400 2021-09-01 A 311,850 a 311,850 direct

WARD SHANE - Officer CHIEF LEGAL OFFICER

2021-08-27 18:41:08 -0400 2021-08-25 A 250,000 a 250,000 direct

STEIN JEFFREY - Director - Officer PRESIDENT & CEO

2021-08-19 16:24:31 -0400 2021-08-19 P 10,000 $1.79 a 415,878 direct 8.1633 7.1429 -0.5102 19.898 26 -0.5102 31

STEIN JEFFREY - Director - Officer PRESIDENT & CEO

2021-08-19 16:24:31 -0400 2021-08-18 P 40,000 $1.72 a 405,878 direct 8.1633 7.1429 -0.5102 19.898 26 -0.5102 31

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CIDARA THERAPEUTICS INC CDTX 2021-10-15 22:15:04 UTC -1.4171 1.4871 2000000
CIDARA THERAPEUTICS INC CDTX 2021-10-15 21:45:03 UTC -1.4171 1.4871 2000000
CIDARA THERAPEUTICS INC CDTX 2021-10-15 21:15:03 UTC -1.4171 1.4871 2000000
CIDARA THERAPEUTICS INC CDTX 2021-10-15 20:45:03 UTC -1.4171 1.4871 2000000
CIDARA THERAPEUTICS INC CDTX 2021-10-15 20:15:03 UTC -1.4171 1.4871 2000000
CIDARA THERAPEUTICS INC CDTX 2021-10-15 19:45:03 UTC -1.4171 1.4871 2000000
CIDARA THERAPEUTICS INC CDTX 2021-10-15 19:15:04 UTC -1.4171 1.4871 2000000
CIDARA THERAPEUTICS INC CDTX 2021-10-15 18:45:03 UTC -1.4171 1.4871 2000000
CIDARA THERAPEUTICS INC CDTX 2021-10-15 18:15:03 UTC -1.4171 1.4871 2000000
CIDARA THERAPEUTICS INC CDTX 2021-10-15 17:45:03 UTC -1.4171 1.4871 2000000
CIDARA THERAPEUTICS INC CDTX 2021-10-15 17:15:03 UTC -1.4171 1.4871 2000000
CIDARA THERAPEUTICS INC CDTX 2021-10-15 16:45:03 UTC -1.414 1.484 2000000
CIDARA THERAPEUTICS INC CDTX 2021-10-15 16:15:03 UTC -1.414 1.484 1700000
CIDARA THERAPEUTICS INC CDTX 2021-10-15 15:45:03 UTC -1.414 1.484 1700000
CIDARA THERAPEUTICS INC CDTX 2021-10-15 15:15:03 UTC -1.414 1.484 1700000
CIDARA THERAPEUTICS INC CDTX 2021-10-15 14:45:02 UTC -1.2897 1.3597 1700000
CIDARA THERAPEUTICS INC CDTX 2021-10-15 14:15:03 UTC -1.2897 1.3597 1700000
CIDARA THERAPEUTICS INC CDTX 2021-10-15 13:45:03 UTC -1.2897 1.3597 1700000
CIDARA THERAPEUTICS INC CDTX 2021-10-15 13:15:03 UTC -1.2897 1.3597 1700000
CIDARA THERAPEUTICS INC CDTX 2021-10-15 12:45:03 UTC -1.2897 1.3597 1700000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments